Addus HomeCare (ADUS) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

ADUS Stock Forecast


Addus HomeCare (ADUS) stock forecast, based on 15 Wall Street analysts, predicts a 12-month average price target of $135.67, with a high of $150.00 and a low of $83.00. This represents a 24.34% increase from the last price of $109.11.

$80 $94 $108 $122 $136 $150 High: $150 Avg: $135.67 Low: $83 Last Closed Price: $109.11

ADUS Stock Rating


Addus HomeCare stock's rating consensus is Buy, based on 15 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 14 Buy (93.33%), 0 Hold (0.00%), 1 Sell (6.67%), and 0 Strong Sell (0.00%).

Buy
Total 15 1 0 14 0 Strong Sell Sell Hold Buy Strong Buy

ADUS Price Target Upside V Benchmarks


TypeNameUpside
StockAddus HomeCare24.34%
SectorHealthcare Stocks 18.80%
IndustryMedical Care Facilities Stocks24.38%

Price Target Trends


1M3M12M
# Anlaysts--6
Avg Price Target--$145.17
Last Closing Price$109.11$109.11$109.11
Upside/Downside--33.05%
Ratings Trends

DateStrong BuyBuyHoldSellStrong SellTotal
Jul, 2538--112
Jun, 2537--111
May, 2537--111
Apr, 2538--112
Mar, 2538--112
Analyst Price Target Forecasts

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 16, 2024Constantine DavidesJMP Securities$150.00$122.9621.99%37.48%
Nov 06, 2024Scott FidelStephens$145.00$124.6816.30%32.89%
Oct 10, 2024Matthew GillmorKeyBanc$150.00$127.4417.70%37.48%
Sep 23, 2024Michael WiederhornOppenheimer$145.00$131.3510.39%32.89%
Aug 08, 2024Frank MorganRBC Capital$141.00$122.2215.37%29.23%
Aug 07, 2024Michael WiederhornOppenheimer$140.00$122.2214.55%28.31%
Jun 07, 2024Michael WiederhornOppenheimer$130.00$116.0712.00%19.15%
May 31, 2024Scott FidelStephens$128.00$111.7314.56%17.31%
May 28, 2024Frank MorganRBC Capital$129.00$111.6115.58%18.23%
Apr 23, 2024Andrew MokBarclays$83.00$93.15-10.90%-23.93%
Analyst Rating Forecasts

DateCompanyPrevious RatingNew RatingRating Change
Dec 16, 2024JMP SecuritiesOutperforminitialise
Oct 11, 2024StephensBuyBuyhold
Oct 10, 2024KeyBancOverweightinitialise
Sep 23, 2024OppenheimerOutperformOutperformhold
Sep 03, 2024StephensBuyBuyhold
Aug 08, 2024Cowen & Co.BuyBuyhold
Aug 08, 2024RBC CapitalOutperformOutperformhold
Aug 07, 2024OppenheimerOutperformOutperformhold
Aug 07, 2024StephensOverweightOverweighthold
Aug 06, 2024OppenheimerUnderperformUnderperformhold

Financial Forecast


EPS Forecast

$2 $3 $4 $5 $6 $7 $8 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$2.12$2.87$2.90$3.85$4.23---
Avg Forecast$2.98$3.42$3.53$4.36$5.23$6.06$6.74$7.46
High Forecast$3.25$3.72$3.59$4.40$5.31$6.25$7.39$7.88
Low Forecast$2.81$3.23$3.47$4.31$5.12$5.85$6.05$7.04
Surprise %-28.86%-16.08%-17.85%-11.70%-19.12%---

Revenue Forecast

$500M $800M $1B $1B $2B $2B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$764.77M$864.50M$951.12M$1.06B$1.15B---
Avg Forecast$766.33M$865.59M$950.22M$1.06B$1.15B$1.43B$1.52B$1.68B
High Forecast$818.89M$924.95M$962.51M$1.10B$1.20B$1.50B$1.52B$1.76B
Low Forecast$733.16M$828.12M$937.59M$1.05B$1.12B$1.40B$1.52B$1.64B
Surprise %-0.20%-0.13%0.10%0.18%0.49%---

Net Income Forecast

$0 $30M $60M $90M $120M $150M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$33.13M$45.13M$46.02M$62.52M$73.60M---
Avg Forecast$25.85M$44.99M$46.36M$62.52M$85.03M$101.08M$112.15M$125.38M
High Forecast$31.02M$53.99M$55.63M$75.02M$86.58M$101.98M$120.47M$128.49M
Low Forecast$20.68M$35.99M$37.09M$50.01M$83.48M$95.38M$98.71M$114.87M
Surprise %28.19%0.31%-0.72%--13.45%---

ADUS Forecast FAQ


Is Addus HomeCare stock a buy?

Addus HomeCare stock has a consensus rating of Buy, based on 15 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 14 Buy, 0 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Addus HomeCare is a favorable investment for most analysts.

What is Addus HomeCare's price target?

Addus HomeCare's price target, set by 15 Wall Street analysts, averages $135.67 over the next 12 months. The price target range spans from $83 at the low end to $150 at the high end, suggesting a potential 24.34% change from the previous closing price of $109.11.

How does Addus HomeCare stock forecast compare to its benchmarks?

Addus HomeCare's stock forecast shows a 24.34% upside, outperforming the average forecast for the healthcare stocks sector (18.80%) and underperforming the medical care facilities stocks industry (24.38%).

What is the breakdown of analyst ratings for Addus HomeCare over the past three months?

  • July 2025: 25.00% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 8.33% Strong Sell.
  • June 2025: 27.27% Strong Buy, 63.64% Buy, 0% Hold, 0% Sell, 9.09% Strong Sell.
  • May 2025: 27.27% Strong Buy, 63.64% Buy, 0% Hold, 0% Sell, 9.09% Strong Sell.

What is Addus HomeCare’s EPS forecast?

Addus HomeCare's average annual EPS forecast for its fiscal year ending in December 2025 is $6.06, marking a 43.26% increase from the reported $4.23 in 2024. Estimates for the following years are $6.74 in 2026, and $7.46 in 2027.

What is Addus HomeCare’s revenue forecast?

Addus HomeCare's average annual revenue forecast for its fiscal year ending in December 2025 is $1.43B, reflecting a 23.97% increase from the reported $1.15B in 2024. The forecast for 2026 is $1.52B, and $1.68B for 2027.

What is Addus HomeCare’s net income forecast?

Addus HomeCare's net income forecast for the fiscal year ending in December 2025 stands at $101.08M, representing an 37.34% increase from the reported $73.6M in 2024. Projections indicate $112.15M in 2026, and $125.38M in 2027.